Controlled clinical study of standardized Andrographis paniculata extract in common cold - a pilot trial
- PMID: 23195187
- DOI: 10.1016/S0944-7113(97)80002-5
Controlled clinical study of standardized Andrographis paniculata extract in common cold - a pilot trial
Abstract
Kanjang(®) tablets (standardized Andrographis paniculata extract) have proven effective in the initial treatment of commond cold and sinusitis. Kanjang(®) tablets is a herbal formula, which has been developed by the Swedish Herbal Institute in Gothenburg. The tablets have shown a beneficial effect with regards to the subjective experience of initial symptoms of common cold and uncomplicated sinusitis, as well as to the duration of the symptoms. The preparation has been used in the Nordic countries for more than 12 years, mainly for reducing symptoms of common cold and sinusitis, and shortening the duration of the symptoms. In this controlled, double-blind study performed as a pilot trial at the Health Center, Hallehälsan, during the autumn of 1992, conducted in 50 patients, both subjective symptoms as well as duration of the symptoms were significantly reduced. From the results evaluated it is quite clear that Kanjang(®) tablets decrease the subjective symptoms of common cold as well as shortening of the period of sick leave significantly.
Copyright © 1996 Gustav Fischer Verlag. Published by Elsevier GmbH.. All rights reserved.
Similar articles
-
Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever.Phytomedicine. 2003 May;10(4):271-85. doi: 10.1078/094471103322004767. Phytomedicine. 2003. PMID: 12809357 Clinical Trial.
-
Prevention of common colds with Andrographis paniculata dried extract. A Pilot double blind trial.Phytomedicine. 1997 Jun;4(2):101-4. doi: 10.1016/S0944-7113(97)80051-7. Phytomedicine. 1997. PMID: 23195395
-
Use of visual analogue scale measurements (VAS) to asses the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study.Phytomedicine. 1999 Oct;6(4):217-23. doi: 10.1016/S0944-7113(99)80012-9. Phytomedicine. 1999. PMID: 10589439 Clinical Trial.
-
Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children.Phytother Res. 2004 Jan;18(1):47-53. doi: 10.1002/ptr.1359. Phytother Res. 2004. PMID: 14750201 Clinical Trial.
-
Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.Explore (NY). 2007 Nov-Dec;3(6):573-84. doi: 10.1016/j.explore.2007.09.004. Explore (NY). 2007. PMID: 18005909 Clinical Trial.
Cited by
-
Efficacy of Kan Jang® in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial.Pharmaceuticals (Basel). 2023 Aug 22;16(9):1196. doi: 10.3390/ph16091196. Pharmaceuticals (Basel). 2023. PMID: 37765004 Free PMC article.
-
Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases.J Pharm Anal. 2023 Jun;13(6):563-589. doi: 10.1016/j.jpha.2023.05.010. Epub 2023 May 20. J Pharm Anal. 2023. PMID: 37440909 Free PMC article. Review.
-
Plant Derived Immunomodulators; A Critical Review.Adv Pharm Bull. 2022 Aug;12(4):712-729. doi: 10.34172/apb.2022.074. Epub 2021 Oct 2. Adv Pharm Bull. 2022. PMID: 36415638 Free PMC article. Review.
-
Perspective: repurposed drugs for COVID-19.Arch Med Sci. 2022 Aug 30;18(5):1378-1391. doi: 10.5114/aoms/152467. eCollection 2022. Arch Med Sci. 2022. PMID: 36160358 Free PMC article.
-
Efficacy of Kan Jang® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial.Pharmaceuticals (Basel). 2022 Aug 17;15(8):1013. doi: 10.3390/ph15081013. Pharmaceuticals (Basel). 2022. PMID: 36015163 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
